•  
  •  
  •  
  •  

2026-07-24 13:16:57

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Mphasis Reports 17.5% YoY Revenue Growth in Q1 FY27; Secures $461 Million in New Deal Wins Driven by AI Demand
  • Fractal Analytics Reports 20% Revenue Growth and 92% Surge in Net Income for Q1 FY27
  • Route Mobile Ltd Financial Results Reveal Strong Operational Top-Line Expansion for Q1 FY27 as Revenue Reaches ₹1,151.51 Crore
  • CyberTech Systems and Software Limited Reports Q1 FY27 Net Profit Up 16% YoY to ₹9.48 Crore as Operational Revenue Reaches ₹68.45 Crore
  • ACME Solar operationalizes 3.62 GWh Battery Energy Storage System projects in Rajasthan

Keywords Selected:  DCGI

Stock Report

  • Wockhardt files fast-acting Insulin Aspart injection with DCGI
  • AstraZeneca Pharma India Ltd receives permission from DCGI for Dapagliflozin Tablets 10 mg
  • ICICI Prudential Life Insurance Company Ltd receives demand notice from DCGI for Rs. 492.06 crores
  • Themis Medicare announces DCGI approval of Remifentanil Hydrochloride 1mg/2mg for injection for import and marketing
  • AstraZeneca Pharma India gets permission from DCGI for Olaparib Film-Coated tablets
  • Themis Medicare Ltd gets add on approval for drug VIRALEX®
  • ZyCoV-D® as a two-dose vaccine receives EUA from DCGI
  • Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276
  • Zydus to launch Oxemia™ a breakthrough treatment for Anemia in patients suffering from CKD
  • DCGI approves Themis Medicare's VIRALEX® for Covid-19 treatment
  • Aurobindo announces DCGI's permission to manufacture and market its generic version of Molnupiravir
  • Strides receives DCGI approval under EUA to commercialize Molnupiravir
  • Sun Pharma receives DCGI approval for Molxvir® in India
  • Cipla receives EUA to launch oral antiviral drug Cipmolnu® in India
  • Zydus develops new treatment for patients suffering from Chronic Kidney Disease

Latest Post

  • Mphasis Reports 17.5% YoY Revenue Growth in Q1 FY27; Secures $461 Million in New Deal Wins Driven by AI Demand
  • Fractal Analytics Reports 20% Revenue Growth and 92% Surge in Net Income for Q1 FY27
  • Route Mobile Ltd Financial Results Reveal Strong Operational Top-Line Expansion for Q1 FY27 as Revenue Reaches ₹1,151.51 Crore
  • CyberTech Systems and Software Limited Reports Q1 FY27 Net Profit Up 16% YoY to ₹9.48 Crore as Operational Revenue Reaches ₹68.45 Crore
  • ACME Solar operationalizes 3.62 GWh Battery Energy Storage System projects in Rajasthan


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025